Efficacy and safety of Tirofiban following intravenous thrombolysis: a systematic review and meta-analysis of randomized controlled trials

Abstract Background The risk of re-occlusion and inadequate reperfusion limits the efficacy of intravenous thrombolysis (IVT) within 4.5 h for acute ischemic stroke (AIS). Tirofiban, a glycoprotein IIb/IIIa inhibitor, has been studied as an adjunctive treatment for patients with acute coronary syndr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sher Bano, Faisal Wali Ahmed, Atif Saeed, Ammar Nawazish, Muhammad Haris, Ayesha Mansoor, Ayesha Ghazal Jamali, Riaz Ahmed, Shaumile Hasan Khan, Numan Akram, Zainab Salahuddin, Muhammad Umar, Iman Osman Abufatima
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-04-01
coleção:	BMC Neurology
Assuntos:	Tirofiban Glycoprotein IIb/IIIa inhibitor Stroke Thrombolysis
Acesso em linha:	https://doi.org/10.1186/s12883-026-04892-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!